MorphoSys News

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 29 10:23 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 26 10:13 ET

SC TO-T/A: Third party tender offer statement (Amendment)

Apr 25 16:36 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 25 10:40 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 24 11:08 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 24 10:08 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 23 10:19 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 22 10:36 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 19 10:19 ET

SC TO-T/A: Third party tender offer statement (Amendment)

Apr 18 16:33 ET

SC 13D: Statement of acquisition of beneficial ownership by individuals-Novartis BidCo AG(11.56%),Novartis Pharma AG(11.56%), etc.

Apr 18 14:37 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 18 10:16 ET

SC 14D9/A: Tender offer solicitation/recommendation statements filed under Rule 14d-9 (Amendment)

Apr 17 16:51 ET

SC TO-T/A: Third party tender offer statement (Amendment)

Apr 17 16:37 ET

SC TO-T/A: Third party tender offer statement (Amendment)

Apr 16 17:11 ET

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 16 10:15 ET

MorphoSys | SC TO-T/A: Third party tender offer statement (Amendment)

Apr 15 15:50 ET

MorphoSys | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 12 10:57 ET

MorphoSys | SC 14D9: Tender offer solicitation/recommendation statements filed under Rule 14d-9

Apr 11 11:59 ET

MorphoSys | SC TO-T: Third party tender offer statement

Apr 11 06:05 ET